Form 4/A for LFMD LifeMD, Inc.
Accepted 2023-05-31 00:00:00 ET · period of report 2023-05-23 · accession 0001362118-23-000035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-05-31 | 2023-05-23 | LFMD | Galluppi Stefan | Chief Innovation Off | P - Purchase | $2.17 | +4,608 | 12.4K | +59% | +$9,999 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 | 2023-05-23 | P | A | 4,608 | $2.17 | 12,449 | D | — | — | (F1) This Form 4 corrects the number of shares purchased. |